Predictive performance of population pharmacokinetic parameters of tianeptine as applied to plasma concentrations from a post-marketing study
Grasela TH, Fiedler-Kelly JB,
Salvadori C, Marey C, Jochemsen R, Loo H.
Center for Pharmacoepidemiology Research,
University at Buffalo, New York.
Eur J Clin Pharmacol. 1993;45(2):123-8.


The predictive ability of population pharmacokinetic parameters of tianeptine, obtained from a mixed effect analysis of pre-marketing pharmacokinetic studies, was evaluated using tianeptine plasma concentrations obtained during a large multi-center post-marketing surveillance study. The mean prediction error was 7.8 and the root mean square prediction error was 52.1 ng/ml when initial estimates of population pharmacokinetic parameters were used to predict drug concentrations in one half of the post-marketing data. When the population parameters were revised to reflect the data collected in the first half of the post-marketing study, the mean prediction error was reduced to -3.2 and the root mean square prediction error was reduced to 29.5 These results suggest that population pharmacokinetic parameters obtained from pre-marketing data may not accurately predict drug concentrations in patients receiving the drug in the post-marketing setting. Once the population parameters are updated to reflect data from the post-marketing period, the predictive ability of the data-base increases, but substantial variability in the prediction error remains.
Acute effects
Tianeptine (Stablon)
Tianeptine: structure
Neurochemical profile
Tinaneptine v amitriptyline
Tianeptine for anxious depressives
Ultra-high dose psychostimulant effect
Tianeptine for anxiety induced by alcohol withdrawal

and further reading

Future Opioids
BLTC Research
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family